1. European Monitoring Centre for Drugs and Drug Addiction. Fentanils and synthetic cannabinoids: driving greater complexity into the drug situation. An update from the EU Early Warning System (June 2018). Luxembourg: Publications Office of the European Union; 2018.
2. Saito T, Namera A, Miura N. A fatal case of MAM-2201 poisoning. Forensic Toxicol. 2013;31(2):333–7.
3. Derungs A, Schwaninger AE, Mansella G, Bingisser R, Kraemer T, Liechti ME. Symptoms, toxicities, and analytical results for a patient after smoking herbs containing the novel synthetic cannabinoid MAM-2201. Forensic Toxicol. 2013;31(1):164–71.
4. Roman M, Wu X, Diao X, Josefsson M, Eriksson C, Kugelberg FC, et al. 25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry. Drug Test Anal. 2016;9(5):680–98.
5. Lewin AH, Seltzman HH, Carroll FI, Mascarella SW, Reddy PA. Emergence and properties of spice and bath salts: a medicinal chemistry perspective. Life Sci. 2014;97(1):9–19.